In other words, CD27, EDA, TNF, TNFRSF12A, TNFRSF13C, and TNFRSF9 expression may also affect the immunotherapy effect on tumours by regulating the expression of immune checkpoint molecules in the tumour microenvironment. Here, TNFRSF13C is linked to neoplasm.